Atlanticus Holdings Co. (NASDAQ:ATLCP – Get Free Report) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 2,900 shares, a growth of 141.7% from the May 15th total of 1,200 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is currently 0.6 days.
Atlanticus Trading Down 0.5%
Shares of NASDAQ:ATLCP opened at $22.20 on Friday. Atlanticus has a 1 year low of $21.66 and a 1 year high of $24.50. The firm has a fifty day moving average price of $22.87 and a 200 day moving average price of $23.23.
Atlanticus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Sunday, June 1st will be issued a $0.4766 dividend. This represents a $1.91 dividend on an annualized basis and a yield of 8.59%. The ex-dividend date is Friday, May 30th.
About Atlanticus
Atlanticus Holdings Corporation, a financial technology company, provides credit and related financial services and products to customers the United States. It operates in two segments, Credit as a Service, and Auto Finance. The Credit as a Service segment originates a range of consumer loan products, such as private label and general purpose credit cards originated by lenders through various channels, including retail and healthcare, direct mail solicitation, digital marketing, and partnerships with third parties; and offers credit to their customers for the purchase of various goods and services, including consumer electronics, furniture, elective medical procedures, healthcare, and home-improvements by partnering with retailers, healthcare providers, and other service providers.
See Also
- Five stocks we like better than Atlanticus
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What is a SEC Filing?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Atlanticus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlanticus and related companies with MarketBeat.com's FREE daily email newsletter.